Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus

The article describes a group of drugs used for comorbidity, the comparative characterization of angiotensin II receptor blockers (ARB) and angiotensin-converting enzyme (ACE) inhibitors, listed on the efficacy and safety data from a representative group of ARBs – azilsartan, presented the results clinical studies on these issues